Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Q1 2026 showed $27M GAAP net income, $749M revenue, and $40M adjusted EBITDA, with membership up 51% YoY. Positive Medicare Advantage sentiment from the CMS 2027 rate increase and a roughly 46% 21-day rally support near-term upside.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Profitability Improved ⢠Liquidity Strengthened ⢠Liabilities Elevated CLOV's latest quarter shows a meaningful turnaround in profitability and cash flow with strong liquidity, but elevated liabilities, accumulated losses, and richer valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Modest upward trend ⢠Post-peak pullback ⢠Key level test Support Level: $4.26â$4.30; secondary $4.10â$4.15 Resistance Level: $4.66, then $5.10 CLOV remains modestly constructive above its last-month average, but the 13% pullback from $5.10 signals caution unless it reclaims $4.66 resistance while holding $4.26â$4.30 support.
Sentiment & News
Key News Insights: ⢠Institutional Buying ⢠AI Catalysts ⢠Insider Selling Clover Health drew institutional interest and highlighted PPO/AI growth catalysts, but insider-selling pressure and a 6.5% share decline signal near-term volatility.
AI Summary
CLOV has shifted from a survival story to a proof-of-durable-profitability investment: its rapid membership growth, expanding margins, positive free cash flow, and debt-free balance sheet support upside, but investors should require sustained medical-cost discipline and delivery on 2026 guidance before underwriting a lasting rerating.
Description
Clover Health Investments, Corp. is a U.S. insurer that offers Medicare Advantage products to eligible beneficiaries, delivering plan administration through its Clover Assistant software platform and operating both PPO and HMO plan types. The company also conducts non-insurance activities alongside its core insurance business. Founded in 2014, Clover Health is headquartered in Franklin, Tennessee.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| May 7 | May 14 | CLOV | Clover Health Investments, Corp. | Q1 2026 showed $27M GAAP net income, $749M revenue, and $40M adjusted EBITDA, with membership up 51% YoY. Positive Medicare Advantage sentiment from the CMS 2027 rate increase and a roughly 46% 21-day rally support near-term upside. | Closed | +23.8% |